Basic Science Tower, SUNY Stony Brook, Stony Brook, NY 11794-8651 / 631-444-3219
STATE UNIVERSITY OF NEW YORK AT STONY BROOK
Medical Scientist (M.D./Ph.D.) Training Program

Walter G. Hanel

1st Year Graduate Student

Department: Pathology

Graduate Program: Genetics

Advisor: Ute Moll (rotating)


Abstract (rotation):

Preceptor: Dr. Sanford Simon, Department of Pathology, SBU

Title:  Mechanism of anthrax lethal factor inhibition by green tea products and antibiotics

Bacillus anthracis is a gram-positive, spore forming bacteria which has been recently used as a bioterrorism weapon. Bacillus anthracis secretes a metalloproteinase, lethal factor (LF), which is hypothesized to be the major cause of morbidity and mortality in humans infected with anthrax. Thus, a major goal in the treatment and prevention of anthrax has been to develop an effective inhibitor of LF to administer to patients upon pre and post exposure to anthrax to prevent LF associated morbidity and mortality. A series of compounds were investigated using three different assays to determine the potency of inhibition and potential for future drug development of these compounds: a FRET-based peptide substrate cleavage assay, Western blotting for the prevention of MEK-2 degradation in cell lysates as well as intact cells, and an MTS cell cytotoxicity assay using human peripheral monocytes isolated from blood. Using thermorubin, an antibiotic derived from the a thermophilic bacterium, and Minocycline, a tetracycline antibiotic, it was shown that Thermorubin can inhibit LF with a strong Ki (2.5uM) and prevent significant(80%) cell death due to LF treatment, while Minocycline exhibited relatively weak activity in the each of the assays tested. Among other compounds tested were a series of polyphenol compounds derived from green tea. The compound epigallocatechin gallate, as well as two O-methylated derivatives of this compound, showed powerful inhibition in each of the assays tested. These results reveal promise in future development of these compounds in the treatment and prevention of Bacillus antracis lethal factor associated morbidity and mortality.

Publications:
(MSTP-supported publications indicated with an *)

Kramer JM., Hanel W., Shen F., Isik N., Malone J.P., Maitra A., Sigurdson W., Swart D., Tocker J., Jin T., Gaffen SL. (2007). Cutting Edge: Identification of a Pre-Ligand Assembly Domain (PLAD) and Ligand Binding Site in the IL-17 Receptor. J Immunology. 179(10): 6379:83

Maitra A., Shen F., Hanel W., Mossman K., Tocker J., Swart D., Gaffen SL. (2007). Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression. Proc Natl Acad Sci. U.S.A. 104(18):7506-11

Tanner MJ., Hanel W., Gaffen SL., Lin X. (2007). CARMA1 coiled-coil domain is involved in the oligomerization and subcellular localization of CARMA1 and is required for T-cell receptor-induced NF-kappaB activation. J Biol Chem. 282(23):17141-7

Last updated on August 21, 2008 3:17 PM Contact the Webmaster